Lanlan Hui

Cancer Research · 2015

A researcher in the Science corpus: 1 paper; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom Lanlan Hui trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Rakesh K. Jain
  2. Peter Carmeliet

Who trusts Lanlan Hui overall

  1. E. Henke

Papers from Lanlan Hui's perspective

Ordered by how strongly the researchers Lanlan Hui trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Different tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6C(high) monocytes. (Cancer Research)
  2. Molecular mechanisms and clinical applications of angiogenesis (Nature)
  3. Microenvironmental regulation of metastasis (Nature Reviews. Cancer)
  4. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival (Nature Medicine)
  5. Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. (Cancer Cell)
  6. Hallmarks of cancer: the next generation. (Cell)
  7. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. (Cell)
  8. Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice. (Cancer Cell)
  9. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. (New England Journal of Medicine)
  10. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer. (New England Journal of Medicine)

Their papers